Minnesota SF 3727: Opiate manufacturer reporting requirements amendments and opiate product registration fee determination process amendments

Status: Referred to Health and Human Services (as of 2024-02-15)

State: Minnesota · Session: 2023-2024 · Bill: SF 3727

Subjects: Drugs and Medicine, Government-State, Health and Health Department

Sponsors: Mann

View Minnesota SF 3727 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.